Data confirms Versamune® HPV has potential as a broadly effective treatment of HPV16-associated cancers – Initiation of Phase 3 trial in HPV16-positive HNSCC planned for Q1 2025 Versamune® HPV + CRT ...
Pegasus Biotech and VIDO Announce Strategic Collaboration to Advance Commercialization of the BPE DNA Platform ...
Engineered cells are a high-value genetic asset that is key to many fields, including biotechnology, medicine, aging, and ...
A new family of enzymes enables precise cuts in single-stranded DNA, offering powerful new tools for genetic engineering and expanding possibilities in biotechnology. (Nanowerk News) A few years ago, ...
Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...
STONY BROOK, NY / ACCESSWIRE / July 13, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has acquired ...
Morning Overview on MSN
POSTECH platform uses non-genetic DNA to control cells without rewriting genes
Researchers at Pohang University of Science and Technology (POSTECH) have built a platform that steers cell behavior using ...
The 2025 MM+M Agency 100 honoree debuted DNAHelix in a bid to help biotech companies develop a unified brand narrative and engage with key stakeholders as they grow. The launch of DNAHelix also ...
The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...
Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results